Health and Fitness Health and Fitness
Wed, February 29, 2012
[ Wed, Feb 29th 2012 ] - Market Wire
Ergoresearch LTD Reports Record Sales and Claims its Twentieth Consecutive Profitable Quarter
[ Wed, Feb 29th 2012 ] - Market Wire
ImmunoCellular Therapeutics Licenses Mesothelin Cancer Antigen from Johns Hopkins University
[ Wed, Feb 29th 2012 ] - Market Wire
Baxter to Present at the Barclays Capital 2012 Global Healthcare Conference
[ Wed, Feb 29th 2012 ] - Market Wire
Sirona Biochem Announces Diabetes Preclinical Results in Chronic Study
[ Wed, Feb 29th 2012 ] - Market Wire
Canadians Living with Diabetes Not Getting Enough Support
[ Wed, Feb 29th 2012 ] - Market Wire
Marshall Edwards CEO to Present at Roth Capital Partners Growth Stock Conference
[ Wed, Feb 29th 2012 ] - Market Wire
Dehaier Medical to Present at the Cowen and Company 32nd Annual Health Care Conference
[ Wed, Feb 29th 2012 ] - Market Wire
Thera Max Cold and Flu Brand Receives Great Benef .. Ongoing Social Media Marketing Awareness Program
[ Wed, Feb 29th 2012 ] - Market Wire
Nektar Therapeutics Announces Agreement to Sell C .. CERA Royalties to Royalty Pharma for $124 Million
[ Wed, Feb 29th 2012 ] - Market Wire
Health Net Announces Appearance at Cowen & Company 32nd Annual Health Care Conference
[ Wed, Feb 29th 2012 ] - Market Wire
NPS Pharmaceuticals Appoints Georges Gemayel, Ph.D., to Board of Directors
[ Wed, Feb 29th 2012 ] - Market Wire
ShangPharma to Report Fourth Quarter and Full Year 2011 Financial Results on March 12, 2012
[ Wed, Feb 29th 2012 ] - Market Wire
Varian Medical Systems to Exhibit X-Ray Tubes and .. gy Enhancements to Improve Digital Imaging at the
[ Wed, Feb 29th 2012 ] - Market Wire
AMRI Expands Quality Control Leadership to Support Future Growth
[ Wed, Feb 29th 2012 ] - Market Wire
Avanir Pharmaceuticals and Concert Pharmaceutical .. to Develop and Commercialize Deuterium-modified D
[ Wed, Feb 29th 2012 ] - Market Wire
Cempra, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference
[ Wed, Feb 29th 2012 ] - Market Wire
BioSpecifics Technologies Corp. Announces Present .. ons at Two Upcoming Investor Conferences in March
[ Wed, Feb 29th 2012 ] - Market Wire
Hi-Tech Pharmacal Receives Final Approval for Levetiracetam Oral Solution
[ Wed, Feb 29th 2012 ] - Market Wire
NuPathe to Present at the Cowen and Company 32nd Annual Health Care Conference
[ Wed, Feb 29th 2012 ] - Market Wire
Celsion to Present at Upcoming Investor Conferences in March 2012
[ Wed, Feb 29th 2012 ] - Market Wire
SET Corp Receives $875,000 Private Investment for Bakken Shale Saltwater Disposal
[ Wed, Feb 29th 2012 ] - Market Wire
Synergetics USA Announces Conference Call to Review Second Quarter of Fiscal Year 2012 Results
[ Wed, Feb 29th 2012 ] - Market Wire
Mylan Launches First Equivalent Product to Lexapro Tablets
[ Wed, Feb 29th 2012 ] - Market Wire
Marina Biotech Presents Advances in Oral Delivery .. of Nucleic Acids at AsiaTIDES Conference in Tokyo
[ Wed, Feb 29th 2012 ] - Market Wire
Dyax Announces Appointment of Dr. Burt Adelman as Chief Medical Officer
[ Wed, Feb 29th 2012 ] - Market Wire
Horizon Pharma Announces $50.8 Million Private Placement
[ Wed, Feb 29th 2012 ] - Market Wire
BioLineRx Announces Receipt of Notice of Allowanc .. ing BCM (BL-1040), a Novel Medical Device for Pre
[ Wed, Feb 29th 2012 ] - Market Wire
Arrowhead Announces Patent Issuance Covering siRNA Inhibitors of HIF-2a (EPAS1)
[ Wed, Feb 29th 2012 ] - Market Wire
Biogen Idec levert aanvraag in bij FDA voor goedk .. ale BG-12 voor behandeling van Multiple Sclerosis
[ Wed, Feb 29th 2012 ] - Market Wire
Columbia Laboratories Will Present March 5th at Cowen and Company Health Care Conference

Columbia Laboratories Will Present March 5th at Cowen and Company Health Care Conference


Published on 2012-02-29 04:08:08 - Market Wire
  Print publication without navigation


LIVINGSTON, N.J.--([ ])--Columbia Laboratories Inc. (Nasdaq: CBRX) announced today that Frank Condella, president and chief executive officer, will present at the Cowen and Company 32nd Annual Health Care Conference. The presentation is scheduled as follows:

Date: Monday, March 5, 2012
Time: 4:30 pm ET
Location: The Boston Marriott Copley Place, Boston, MA
Live webcast:

[ www.columbialabs.com ] in aEventsa under the aInvestorsa tab

About Columbia Laboratories

Columbia Laboratories, Inc. is developing products that utilize its novel bioadhesive drug delivery technologies to optimize drug delivery in a controlled, sustained manner. For more information, please visit [ www.columbialabs.com ].

Contributing Sources